Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhaled imatinib for treatment of pulmonary arterial hypertension (PAH)

Inhaled imatinib for treatment of pulmonary arterial hypertension (PAH)

US Patent 11980689 · Granted May 14, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aerosol pirfenidone and pyridone analog compounds and uses thereof2025
Specially formulated compositions of inhaled nintedanib and nintedanib salts2024
Aerosol pirfenidone and pyridone analog compounds and uses thereof2024
Aerosol pirfenidone and pyridone analog compounds and uses thereof2023
Aerosol pirfenidone and pyridone analog compounds and uses thereof2022
Aerosol pirfenidone and pyridone analog compounds and uses thereof2022
Specially formulated compositions of inhaled nintedanib and nintedanib salts2021
Aerosol pirfenidone and pyridone analog compound and uses thereof2021
Aerosolized fluoroquinolones and uses thereof2021
Aerosol fluoroquinolone formulations for improved pharmacokinetics2020
Aerosol pirfenidone and pyridone analog compounds and uses thereof2020
Aerosol fluoroquinolone formulations for improved pharmacokinetics2018